Publications & Works

Publication Network
Articles 23
All (23)
SCI-E, SSCI, AHCI (18)
SCI-E, SSCI, AHCI, ESCI (23)
ESCI (3)
Scopus (23)
TRDizin (5)

1. The Reply

Tuncay F. Y., Ceylanoglu K. S., GÜNTEKİN ERGÜN S., TARLAN B., KONUK O.
TURK OFTALMOLOJI DERGISI-TURKISH JOURNAL OF OPHTHALMOLOGY , vol.54, no.4, pp.247-250, 2024 (ESCI, Scopus, TRDizin) Creative Commons License

2. The Role of FOXP3 Polymorphisms in Graves' Disease with or without Ophthalmopathy in a Turkish Population

Tuncay F. Y., Ceylanoglu K. S., GÜNTEKİN ERGÜN S., TARLAN B., KONUK O.
TURK OFTALMOLOJI DERGISI-TURKISH JOURNAL OF OPHTHALMOLOGY , vol.54, no.2, pp.69-75, 2024 (ESCI, Scopus, TRDizin)

3. Novel indole-pyrazole hybrids as potential tubulin-targeting agents; Synthesis, antiproliferative evaluation, and molecular modeling studies

Hawash M., Ergun S., KAHRAMAN D. C., OLĞAÇ A., Hamel E., Cetin-Atalay R., et al.
Journal of Molecular Structure , vol.1285, 2023 (SCI-Expanded, Scopus)

4. EVALUATION OF MITOCHONDRIAL DNA MUTATIONS IN SIX FAMILIES BY RESEQUENCING ARRAY MİTOKONDRİYAL DNA MUTASYONLARININ TEKRAR DİZİLEME ARRAY YÖNTEMİ İLE ALTI AİLEDE DEĞERLENDİRİLMESİ

Kolbaşi Demircioğlu G., Güntekin Ergün S., Gücüyener K., Perçin F. E., Ergün M. A.
Istanbul Tip Fakultesi Dergisi , vol.86, no.1, pp.78-87, 2023 (Scopus, TRDizin) Sustainable Development

5. Vicinal Diaryl-Substituted Isoxazole and Pyrazole Derivatives with In Vitro Growth Inhibitory and In Vivo Antitumor Activity

Turanli S., NALBAT E., LENGERLİ D., İBİŞ K., Ergun S., Guzelcan E., et al.
ACS OMEGA , vol.7, no.41, pp.36206-36226, 2022 (SCI-Expanded, Scopus)

6. Clinical and molecular evaluation of MEFV gene variants in the Turkish population: a study by the National Genetics Consortium

DÜNDAR M., FAHRİOGLU U., Yildiz S. H., Bakir-Gungor B., TEMEL Ş. G., AKIN H., et al.
FUNCTIONAL & INTEGRATIVE GENOMICS , vol.22, no.3, pp.291-315, 2022 (SCI-Expanded, Scopus)

7. Design and synthesis of novel substituted indole-acrylamide derivatives and evaluation of their anti-cancer activity as potential tubulin-targeting agents

Hawash M., KAHRAMAN D. C., OLĞAÇ A., Ergun S., Hamel E., Cetin-Atalay R., et al.
JOURNAL OF MOLECULAR STRUCTURE , vol.1254, 2022 (SCI-Expanded, Scopus) Sustainable Development

8. EGF-SNX3-EGFR axis drives tumor progression and metastasis in triple-negative breast cancers

Cicek E., Circir A., Oyken M., Akbulut Caliskan O., DÖKEN D. N., Guntekin Ergun S., et al.
Oncogene , vol.41, no.2, pp.220-232, 2022 (SCI-Expanded, Scopus)

9. Identification of an mRNA isoform switch for HNRNPA1 in breast cancers

Erdem M., ÖZGÜL İ., DÖKEN D. N., Gurcuoglu I., Guntekin Ergun S., Cetin-Atalay R., et al.
Scientific Reports , vol.11, no.1, 2021 (SCI-Expanded, Scopus) Creative Commons License

10. Synthesis of novel indole-isoxazole hybrids and evaluation of their cytotoxic activities on hepatocellular carcinoma cell lines

Hawash M., KAHRAMAN D. C., Ergun S., Cetin-Atalay R., BAYTAŞ S.
BMC Chemistry , vol.15, no.1, 2021 (Scopus)

11. Genome-wide association and whole exome sequencing studies reveal a novel candidate locus for restless legs syndrome

ERGÜN U., Say B., Ergun S., PERÇİN F. E., Inan L., Kaygisiz S., et al.
EUROPEAN JOURNAL OF MEDICAL GENETICS , vol.64, no.4, 2021 (SCI-Expanded, Scopus)

12. Role of glutathione S-transferase P1 polymorphism in early transplant complications in patients undergoing allogeneic stem cell transplantation

Saritas H., Suyani E., Güntekin S., Zeynep A., ERGÜN M. A., ÇELİK B., et al.
Journal of Cancer Research and Therapeutics , vol.17, no.2, pp.565-573, 2021 (SCI-Expanded, Scopus)

13. Is cervical swab an efficient method for developing a new noninvasive prenatal diagnostic test for numerical and structural chromosome anomalies?

Yurtcu E., Karçaaltıncaba D., Kazan H. H., Ozdemir H., Yirmibeş Karaoğuz M., Calis P., et al.
TURKISH JOURNAL OF MEDICAL SCIENCES , vol.51, no.3, pp.1043-1048, 2021 (SCI-Expanded, Scopus, TRDizin) Sustainable Development

14. Intelligent Ratio: A New Method for Carrier and Newborn Screening in Spinal Muscular Atrophy

Cavdarli B., Ozturk F. N., Guntekin Ergun S., ERGÜN M. A., DOĞAN Ö., Percin E. F.
GENETIC TESTING AND MOLECULAR BIOMARKERS , vol.24, no.9, pp.569-577, 2020 (SCI-Expanded, Scopus) Sustainable Development

15. Inherited eye diseases in Turkey: Current approaches and future directions

Yaylacıoğlu Tuncay F., Güntekin Ergün S., Oner A., Turan A., Özmert E., Ergün M. A., et al.
AMERICAN JOURNAL OF MEDICAL GENETICS PART C-SEMINARS IN MEDICAL GENETICS , vol.184, no.3, pp.773-781, 2020 (SCI-Expanded, Scopus)

16. Identification of small-molecule urea derivatives as novel NAMPT inhibitors via pharmacophore-based virtual screening

Ozgencil F., EREN G., ÖZKAN Y., GÜNTEKİN ERGÜN S., Cetin-Atalay R.
BIOORGANIC & MEDICINAL CHEMISTRY , vol.28, no.1, 2020 (SCI-Expanded, Scopus)

17. A new approach (EDIZ) for big data variant prioritization

ERGÜN M. A., Ergun S., Percin E. F.
NETWORK MODELING AND ANALYSIS IN HEALTH INFORMATICS AND BIOINFORMATICS , vol.8, no.1, 2019 (ESCI, Scopus)

18. Pharmacophore modeling and virtual screening studies to identify novel selective SIRT2 inhibitors

Eren G., Bruno A., Guntekin-Ergun S., Cetin-Atalay R., Ozgencil F., Özkan Y., et al.
JOURNAL OF MOLECULAR GRAPHICS & MODELLING , vol.89, pp.60-73, 2019 (SCI-Expanded, Scopus) Sustainable Development

19. Single-Nucleotide Polymorphisms in IL23R-IL12RB2 (rs1495965) Are Highly Prevalent in Patients with Behcet’s Uveitis and Vary Between Populations

Kramer M., Hasanreisoglu M., Weiss S., Kumova D., Schaap-Fogler M., Guntekin-Ergun S., et al.
Ocular Immunology and Inflammation , vol.27, no.5, pp.766-773, 2019 (SCI-Expanded, Scopus)

20. The relation between isolated micropenis in childhood with CAG and GGN repeat polymorphisms in the androgen receptor gene

TUĞ E., Güntekin Ergün S., ERGÜN M. A., Dilek F. N., Perçin E. F.
Turkish Journal of Medical Sciences , vol.48, no.2, pp.430-434, 2018 (SCI-Expanded, Scopus, TRDizin)

21. Analysis of genetics and risk factors of Alzheimer's Disease

Panpalli Ates M., Karaman Y., Guntekin S., ERGÜN M. A.
Neuroscience , vol.325, pp.124-131, 2016 (SCI-Expanded, Scopus)

22. The evaluation of long-term effects of ionizing radiation through measurement of current sister chromatid exchange (SCE) rates in radiology technologists, compared with previous SCE values

TUĞ E., KAYHAN G., Kan D., Guntekin S., ERGÜN M. A.
Mutation Research - Genetic Toxicology and Environmental Mutagenesis , vol.757, no.1, pp.28-30, 2013 (SCI-Expanded, Scopus)

23. The prognostic role of hemochromatosis H63D allele in allogeneic hematopoietic stem cell transplantation

Sucak G. T., Yaşar D. G., YEGİN Z. A., ERGÜN M. A., ÖZKURT Z. N., Akı Ş. Z., et al.
Annals of Hematology , vol.91, no.8, pp.1281-1287, 2012 (SCI-Expanded, Scopus)
Papers Presented at Peer-Reviewed Scientific Conferences 19

1. Meme Kanserinde Vus'ların Sinyal Yolakları Ile Ilişkisi

GÜNTEKİN ERGÜN S., ŞAHİN F. İ.
15.ulusal tıbbi genetik kongresi, Muğla, Turkey, 9 - 13 November 2022, (Summary Text)

2. The story of a novel compound targeting the Hippo pathway in hepatocellular carcinoma

GÜNTEKİN ERGÜN S.
2nd International Multidisciplinary Cancer Research Congress, Giresun, Turkey, 21 - 24 July 2022, (Summary Text)

3. Genome-Wide Association and Whole Exome Sequencing Studies reveal a Novel Candidate Locus for Restless Legs Syndrome

ERGÜN U., SAY B., GÜNTEKİN ERGÜN S., PERÇİN F. E., İnan L., KAYGISIZ Ş., et al.
54th European Society of Human Genetics (ESHG) Conference:Virtual Conference, 28 - 31 August 2021, (Summary Text)

4. Hepatosellüler kanserde YAP proteini hedefli yeni bileşiklerin belirlenmesi

GÜNTEKİN ERGÜN S., SARI S., AVCI A., DİNÇER P. R.
17. Ulusal Tıbbi Biyoloji ve Genetik Kongresi, 28 - 31 October 2021, (Summary Text)

5. Hepatosellüler kanserde MST1/2 kinaz inhibitörünün etkisi

GÜNTEKİN ERGÜN S., DİNÇER P. R.
Ankara Hematoloji ve Onkoloji Günleri, Ankara, Turkey, 2 - 04 April 2021, (Summary Text)

6. Hepatosellüler Kanserde MST1/2 Kinaz İnhibitörünün Etkisi

Güntekin Ergün S., Ünsal Ş., Dinçer P. R.
Ankara Hematoloji ve Onkoloji Günleri, Ankara, Turkey, 02 April 2021, (Unpublished) Sustainable Development

7. KONJENİTAL KALP HASTALIĞI OLAN ÇOCUKLARDA APO E GEN POLİMORFİZMİNİN NÖRO-BİLİŞSEL İŞLEVLERE ETKİSİ

BEDİR DEMİRDAĞ T., GÜCÜYENER K., SOYSAL ACAR A. Ş., GÜNTEKİN ERGÜN S., ERGÜN M. A., OLGUNTÜRK F. R.
22. PEDİATRİ GÜNLERİ, İzmir, Turkey, 25 - 27 March 2021, (Full Text)

8. Creating Rare Disease Specific CRISPR-Cas9 Platforms in Zebrafish and Ensuring Their Sustainability in Hacettepe University Zebrafish Research Laboratory: Challenges in mimicking missense variants

Yaylacıoğlu Tuncay F., Kural Mangıt E., Kayman Kürekçi G., Güntekin Ergün S., Dinçer P. R.
2nd Zebrafish Workshop, Turkey, Ankara, Turkey, 18 March 2021, pp.7, (Summary Text)

9. Effect of MST1/2 kinase inhibitor on LGMD2R phenotype

Güntekin Ergün S., Dinçer P. R.
14. Ulusal Tıbbi Genetik Kongresi, Ankara, Turkey, 20 - 22 November 2020, pp.56, (Summary Text)

10. Synthesis of 3-4-diaryl-5-methylisoxazoles with potent antiproliferative activity against a panel of human liver and breast cancer cell lines

LENGERLİ D., TURANLI S., ÇALIŞKAN B., AKHAN GÜZELCAN E., GÜNTEKİN ERGÜN S., ATALAY R., et al.
EFMC-ISMC&EFMC-YMCS, 09 September 2020, (Summary Text)

11. OSTEOPOROSIS PSEUDOGLIOMA SYNDROME DUE TO LRP5 GENE MUTATION

Güntekin Ergün S., Gümüş-Akay G., Ergün M. A., Perçin F. E., Dinçer P. R.
2. Genetikte Güncel Tedaviler, Konya, Turkey, 5 - 06 October 2019, pp.3, (Summary Text)

12. A new approach (EDIZ) for Big Data Variant Prioritization

ERGÜN M. A., GÜNTEKİN ERGÜN S., PERÇİN F. E.
13th Balkan Congress of Human Genetics, Edirne, Turkey, 17 - 20 April 2019, vol.22, pp.1-234, (Summary Text)

13. Prosigna assay for treatment decisions in early breast cancer: A single center, decision impact study

ESİN E., Öksüzoğlu B. O., MARKOÇ F., BİLGETEKİN İ., YILDIZ F., GÜNTEKİN ERGÜN S., et al.
2018 San Antonio Breast Cancer Symposium, San-Antonio, Northern Mariana Islands, 4 August - 08 December 2018, (Summary Text)

14. A new method for analysis of whole exome sequencing data (SELIM) depending on variant prioritization

ERGÜN M. A., Unal A., GÜNTEKİN ERGÜN S., PERÇİN F. E.
50th European Society of Human Genetics Conference, Denmark, 27 - 30 May 2017, (Summary Text)

15. A NEW METHOD FOR ANALYSIS OF EXOME SEQUENCING DATA DEPENDING ON VARIANT PRIORITIZATION

ERGÜN M. A., unal a., GÜNTEKİN ERGÜN S., PERÇİN F. E.
Erciyes Medical Genetics Days 2018, Kayseri, Turkey, 7 - 10 March 2018, (Summary Text)

16. DEVELOPING A NEW SCREENING KIT FOR DETERMINATION OF SPINAL MUSCULAR ATROPHY CARRIER PATIENTS WITH REAL-TIME PCR METHOD

ÇAVDARLI B., DİLEK F. N., GÜNTEKİN ERGÜN S., ERGÜN M. A., PERÇİN F. E.
Erciyes Medical Genetics Days 2018, Kayseri, Turkey, 7 - 10 March 2018, (Summary Text)

17. Meme kanserinin subtiplemesinde qRT-PCR ve nCounter teknolojisi kullanan Prosigna kitinin sonuçlarının karşılaştırılması

GÜNTEKİN ERGÜN S., İRİGÜL SÖNMEZ Ö., ÜNER A., Çetin Atalay R.
XV. ULUSAL TIBBİ BİYOLOJİ VE GENETİK KONGRESİ, Ölüdeniz/Fethiye/Muğla, Turkey, 26 - 29 October 2017, (Summary Text)

18. Genetic analysis of CHST6 and TGFBI in Turkish patients with corneal dystrophies: Five novel variations in CHST6

Yaylacıoğlu Tuncay F., Kayman Kürekçi G., Güntekin Ergün S., Paşaoğlu Ö. T., Akata R. F., Dinçer P. R.
ESHG Conference, Vienna, Austria, 27 May 2017, (Unpublished)

19. Genetic analysis of the CHST6 end TGFBI genes in Turkish patients with corneal dystrophies five novel variations in CHST6

Yaylacıoğlu Tuncay F., Kayman Kürekçi G., Güntekin Ergün S., Paşaoğlu Ö. T., Eke R., Dinçer P. R.
50.Turkiye OIftalmoloji Derneği Ulusal Kongresi, Antalya, Turkey, 9 - 13 November 2016, (Unpublished)
Books 1

1. Temel DNA Teknolojileri:DNA amplifikasyonu,nükleik asit hibridizasyonu ve DNA dizileme

GÜNTEKİN ERGÜN S.
in: İnsan Moleküler Genetiği, Pervin Dinçer, Editor, Hipokrat, Ankara, pp.161-201, 2020
Metrics

Publication

43

Publication (WoS)

23

Publication (Scopus)

23

Citation (WoS)

3

H-Index (WoS)

1

Citation (Scopus)

186

H-Index (Scopus)

7

Project

11

Open Access

2
UN Sustainable Development Goals
SDG 3: GOAL 3: GOOD HEALTH AND WELL-BEING
SDG 8: GOAL 8: DECENT WORK AND ECONOMIC GROWTH
SDG 16: GOAL 16: PEACE, JUSTICE AND STRONG INSTITUTIONS